Anti-Insulin Antibodies and Metabolic Deterioration After Interruption of Continuous Subcutaneous Insulin Infusion

Scheen, A J; Henrivaux, P; Jandrain, B; Lefebvre, P J

doi:10.2337/diacare.9.6.673

Article navigation

Letters and Comments| November 01 1986

Anti-Insulin Antibodies and Metabolic Deterioration After Interruption of Continuous Subcutaneous Insulin Infusion

A J Scheen, MD;

A J Scheen, MD

Division of Diabetes, Institute of Medicine, Hôpital de Bavière

Liège, Belgium

Search for other works by this author on:

This Site

PubMed

Google Scholar

P Henrivaux, MD;

P Henrivaux, MD

Division of Diabetes, Institute of Medicine, Hôpital de Bavière

Liège, Belgium

Search for other works by this author on:

This Site

PubMed

Google Scholar

B Jandrain, MD;

B Jandrain, MD

Division of Diabetes, Institute of Medicine, Hôpital de Bavière

Liège, Belgium

Search for other works by this author on:

This Site

PubMed

Google Scholar

P J Lefebvre, MD, PhD

Division of Diabetes, Institute of Medicine, Hôpital de Bavière

Liège, Belgium

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence to Dr. P. J. Lefèbvre, Division of Diabetes, Institute of Medicine, Hôpital de Bavière, 66 Boulevard de la Constitution, B-4020 Liège, Belgium.

Diabetes Care 1986;9(6):673–674

https://doi.org/10.2337/diacare.9.6.673

PubMed:

3803158

Anti-Insulin Antibodies and Metabolic Deterioration After Interruption of Continuous Subcutaneous Insulin Infusion

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Anti-Insulin Antibodies and Metabolic Deterioration After Interruption of Continuous Subcutaneous Insulin Infusion

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only